Table 4.
ART procedures and ovarian stimulation details among the three compared groups divided according to BAI scores
| Groups | Intergroup comparisons: P-value | ||||||
|---|---|---|---|---|---|---|---|
| Group A (n= 36) | Group B (n= 24) | Group C (n= 19) | A vs B | A vs C | B vs C | ||
| ART | cIVF | 30.55%(n=11) | 25%(n=6) | 10.52%(n=2) | 0.61 | 0.24 | 0.27 |
| Procedure | ICSI | 66.67%(n=24) | 75%(n=18) | 84.22%(n=16) | |||
| Half-ICSI | 2.78%(n=1) | 0%(n=0) | 5.26%(n=1) | ||||
| Ovarian stimulation protocol | Antagonist | 36.11%(n=13) | 29.16%(n=7) | 73.68%(n=14) | 0.37 | 0.014* | 0.009* |
| Short agonist | 38.88%(n=14) | 58.33%(n=14) | 10.53%(n=2) | ||||
| Long agonist | 22.22%(n=8) | 8.33%(n=2) | 5.26%(n=1) | ||||
| Mild stimulation | 2.79%(n=1) | 7.18%(n=1) | 10.53%(n=2) | ||||
| Endometrial thickness (mm) | 9.80±2.49 | 9.31±1.80 | 9.52±1.60 | 0.446 | 0.667 | 0.708 | |
| E2 on the day of ovulation triggering (UI/l) | 1413.81±853.44 | 1651.77±1043.31 | 1236.31± 874.10 | 0.362 | 0.480 | 0.179 | |
*
: Statistically significant difference (p<0.05); Data are presented as mean ± SD or frequency (%)